These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21752954)

  • 41. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8
    Li SS; Kochar NK; Elizaga M; Hay CM; Wilson GJ; Cohen KW; De Rosa SC; Xu R; Ota-Setlik A; Morris D; Finak G; Allen M; Tieu HV; Frank I; Sobieszczyk ME; Hannaman D; Gottardo R; Gilbert PB; Tomaras GD; Corey L; Clarke DK; Egan MA; Eldridge JH; McElrath MJ; Frahm N;
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28931520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
    Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
    Nyombayire J; Anzala O; Gazzard B; Karita E; Bergin P; Hayes P; Kopycinski J; Omosa-Manyonyi G; Jackson A; Bizimana J; Farah B; Sayeed E; Parks CL; Inoue M; Hironaka T; Hara H; Shu T; Matano T; Dally L; Barin B; Park H; Gilmour J; Lombardo A; Excler JL; Fast P; Laufer DS; Cox JH;
    J Infect Dis; 2017 Jan; 215(1):95-104. PubMed ID: 28077588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.
    Munseri PJ; Kroidl A; Nilsson C; Joachim A; Geldmacher C; Mann P; Moshiro C; Aboud S; Lyamuya E; Maboko L; Missanga M; Kaluwa B; Mfinanga S; Podola L; Bauer A; Godoy-Ramirez K; Marovich M; Moss B; Hoelscher M; Gotch F; Stöhr W; Stout R; McCormack S; Wahren B; Mhalu F; Robb ML; Biberfeld G; Sandström E; Bakari M
    PLoS One; 2015; 10(4):e0119629. PubMed ID: 25875843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [DNA vaccination via in vivo electroporation can elicit specific immune response against highly pathogenic H5N1 influenza viral structural antigens in mice].
    Wang W; Chen H; Tan WJ; Deng Y; Wang M; Liu Y; Yin X; Zhang K; Guan J; Zhou JF; Shu YL; Ruan L
    Bing Du Xue Bao; 2010 May; 26(3):170-5. PubMed ID: 20572336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice.
    Chin'ombe N; Bourn WR; Williamson AL; Shephard EG
    Virol J; 2009 Jun; 6():87. PubMed ID: 19555490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.
    Okada E; Sasaki S; Ishii N; Aoki I; Yasuda T; Nishioka K; Fukushima J; Miyazaki J; Wahren B; Okuda K
    J Immunol; 1997 Oct; 159(7):3638-47. PubMed ID: 9317164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).
    Churchyard GJ; Morgan C; Adams E; Hural J; Graham BS; Moodie Z; Grove D; Gray G; Bekker LG; McElrath MJ; Tomaras GD; Goepfert P; Kalams S; Baden LR; Lally M; Dolin R; Blattner W; Kalichman A; Figueroa JP; Pape J; Schechter M; Defawe O; De Rosa SC; Montefiori DC; Nabel GJ; Corey L; Keefer MC;
    PLoS One; 2011; 6(8):e21225. PubMed ID: 21857901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation.
    Vandermeulen G; Daugimont L; Richiardi H; Vanderhaeghen ML; Lecouturier N; Ucakar B; Préat V
    Pharm Res; 2009 Jul; 26(7):1745-51. PubMed ID: 19384465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of humoral immunity of hepatitis D virus DNA vaccine generated in mice by using different dosage, gene gun immunization, and in vivo electroporation.
    Shiau YT; Huang YH; Wu JC; Tao MH; Syu W; Chang FY; Lee SD
    J Chin Med Assoc; 2006 Jan; 69(1):7-13. PubMed ID: 16447920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
    Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
    Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity.
    Sang H; Pisarev VM; Munger C; Robinson S; Chavez J; Hatcher L; Parajuli P; Guo Y; Talmadge JE
    Vaccine; 2003 Jun; 21(21-22):3019-29. PubMed ID: 12798646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
    Asbach B; Kliche A; Köstler J; Perdiguero B; Esteban M; Jacobs BL; Montefiori DC; LaBranche CC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Landucci G; Forthal DN; Seaman MS; Hawkins N; Self SG; Sato A; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Francis J; Galmin L; Ding S; Heeney JL; Pantaleo G; Wagner R
    J Virol; 2016 Apr; 90(8):4133-4149. PubMed ID: 26865719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague.
    Albrecht MT; Livingston BD; Pesce JT; Bell MG; Hannaman D; Keane-Myers AM
    Vaccine; 2012 Jul; 30(32):4872-83. PubMed ID: 22633906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.
    Bernelin-Cottet C; Urien C; McCaffrey J; Collins D; Donadei A; McDaid D; Jakob V; Barnier-Quer C; Collin N; Bouguyon E; Bordet E; Barc C; Boulesteix O; Leplat JJ; Blanc F; Contreras V; Bertho N; Moore AC; Schwartz-Cornil I
    J Control Release; 2019 Aug; 308():14-28. PubMed ID: 31265882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
    Elizaga ML; Li SS; Kochar NK; Wilson GJ; Allen MA; Tieu HVN; Frank I; Sobieszczyk ME; Cohen KW; Sanchez B; Latham TE; Clarke DK; Egan MA; Eldridge JH; Hannaman D; Xu R; Ota-Setlik A; McElrath MJ; Hay CM;
    PLoS One; 2018; 13(9):e0202753. PubMed ID: 30235286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
    Huang X; Liu L; Ren L; Qiu C; Wan Y; Xu J
    Vaccine; 2007 Dec; 25(52):8874-84. PubMed ID: 18061316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases.
    Santos S; Ramírez M; Miranda E; Reyes N; Martínez O; Acosta-Santiago M; Rivera JM; Otero M
    J Immunol Res; 2019; 2019():3409371. PubMed ID: 31240233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electroporation enables plasmid vaccines to elicit CD8+ T cell responses in the absence of CD4+ T cells.
    Dayball K; Millar J; Miller M; Wan YH; Bramson J
    J Immunol; 2003 Oct; 171(7):3379-84. PubMed ID: 14500631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transdermal delivery of plasmid encoding truncated nucleocapsid protein enhanced PRRSV-specific immune responses.
    Suradhat S; Wongyanin P; Sirisereewan C; Nedumpun T; Lumyai M; Triyarach S; Chaturavittawong D; Paphavasit T; Panyatong R; Thanawongnuwech R
    Vaccine; 2016 Jan; 34(5):609-615. PubMed ID: 26724543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.